Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center,Randomized,Double Blind, Double Dummy,Placebo Controlled, Efficacy and Safety Study of HS-25 in Combination With Atovastatin in Adults With Primary Hypercholesterolemia

NCT03464682 is registered in ClinicalTrials.gov with Zhejiang Hisun Pharmaceutical Co. Ltd. as lead sponsor.

NCT NCT03464682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03464682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center,Randomized,Double Blind, Double Dummy,Placebo Controlled, Efficacy and Safety Study of HS-25 in Combination With Atovastatin in Adults With Primary Hypercholesterolemia
Lead sponsor
Zhejiang Hisun Pharmaceutical Co. Ltd.
Phase
Phase 3
Overall status
Unknown status
Start date
February 28, 2015
Completion date
May 28, 2019
Enrollment
720 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

primary hypercholesterolemia